What is Allergy?
Allergy operates as a specialized clinic dedicated to the diagnosis and treatment of a wide spectrum of allergic conditions and immunological disorders. Services include managing allergic rhinitis, asthma, chronic sinus diseases, food allergies, and severe allergic reactions. The clinic employs advanced testing methods such as environmental allergy skin testing and allergen immunotherapy, alongside pulmonary and food allergy testing. Their commitment is to provide high-quality, compassionate care to both children and adults, aiming for the highest patient satisfaction.
How much funding has Allergy raised?
Allergy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Allergy
PPP
Public-Private Partnership
What's next for Allergy?
With the recent strategic investment, Allergy is poised to enhance its service offerings and potentially expand its reach. The substantial capital infusion, indicated by the $150K in total funding, suggests a phase of scaling operations, further research and development into treatment modalities, or strategic acquisitions. This late-stage funding context implies a focus on solidifying market position and driving innovation within the allergy and immunology field.
See full Allergy company page
